Everything changes — don’t be afraid.
Joined March 2010
- Tweets 97
- Following 183
- Followers 100
- Likes 166
3 Photos and videos
Jason Fontenot retweeted
13 May 2025
We are Stylus Medicine - an in vivo genetic medicines company with a bold vision to reimagine and expand the reach of transformative genetic medicines, starting with in vivo CAR-T therapies. Learn more: businesswire.com/news/home/2…
2
19
853
12 May 2025
Exclusive: Patrick Hsu’s startup Stylus Medicine launches, looks beyond CRISPR for gene insertion tech - endpts.com/exclusive-patrick…
62
Jason Fontenot retweeted
14 Mar 2025
Zinc Finger Repressors mediate widespread PRNP lowering in the nonhuman primate brain and profoundly extend survival in prion disease mice | bioRxiv. Impressive work, exciting prospect for human study. biorxiv.org/content/10.1101/…
1
7
27
2,531
Jason Fontenot retweeted
20 Jun 2023
Interested in our innovative approach to use iPSCs as a renewable source of allogeneic cells to enable Treg cell therapy manufacturing at scale? Helen Fong, Sangamo's Sr. Scientist joins the @FOCISimmunology Meeting for an oral presentation. Learn more: bit.ly/3J2s9CS
2
3
9
1,839
Jason Fontenot retweeted
19 May 2023
It’s the last day at #ASGCT23 and we’re excited to wrap up a total of 14 presentations featuring progress across our pipeline. For the latest on all of our presentations, visit our website: bit.ly/43mWO5R
2
2
14
2,148
Jason Fontenot retweeted
18 May 2023
Today we’re showcasing our Viral Delivery Capabilities for Neurology. To discover how our cutting-edge delivery science is progressing, visit the website: bit.ly/43mWO5R #ASGCT23
2
4
10
1,700
Jason Fontenot retweeted
2 May 2023
Join us at #ASGCT23, where we’ll showcase progress in our pre-clinical programs, including innovations in epigenetic regulation for neurological disorders & our latest advancements in AAV capsid engineering for delivery. See details: bit.ly/3HvNDHD #ZincFinger
2
4
11
1,822
Jason Fontenot retweeted
27 Sep 2022
Using #Tregs no less!
Job alert from Denise Fitzgerald:
Research Technician post available in Fitzgerald lab - come join us in Belfast to figure out how to repair the brain!
Closing date 3rd Oct 2022.
More details here:
hrwebapp.qub.ac.uk/tlive_web…
2
8
Jason Fontenot retweeted
16 Sep 2022
Zietler presenting amazing data on Prnp knockdown and prion survival benefits by AAV delivered zinc finger by mouse tail vein injection. Wow this is so exciting. Sangamo therapeutics and the irrepressible Minikel Vallabh team 👏 👏 👏 my surprise good news of #prion2022
1
5
27
18 May 2022
Sangamo AAV engineering is firing on all cylinders
17 May 2022
Sr. Scientist David Ojala’s presentation at #ASGCT22 shared exciting progress of our proprietary approach to engineering novel AAV capsids for improved brain delivery. Proud to be part of a scientific team working so hard to improve care options for patients! @SangamoTx
2
7
Jason Fontenot retweeted
17 May 2022
Today at 4pm ET, join our oral presentation at #ASGCT22 to learn how AAV capsids are designed to provide broad CNS access while minimizing exposure to pre-existing anti-AAV antibodies. More: bit.ly/3xKCMW0 #ASGCT #GenomicMedicine #GeneTherapy #CellTherapy
1
4
6
Jason Fontenot retweeted
18 May 2022
Love when our @SangamoTX team has an excuse to get together for food, great science talk and lots of laughs. A fun evening with brilliant colleagues! Now enjoying Day 3 of #ASGCT22.
2
2
13
Jason Fontenot retweeted
18 May 2022
What an inspirational call to action by keynote #ASGCT22 speaker, former NIH director Francis Collins! He says that gene-based therapies are working, but there are thousands of rare diseases still waiting for treatment. #GenomicMedicine #GeneTherapy @SangamoTx
2
9
18 May 2022
The future of cell engineering is here…
16 May 2022
View our poster at #ASGCT22 today to learn more about the efficiency and specificity of multiplexed, epigenetic cell engineering using zinc finger guided transcription factors. Details: bit.ly/3xKCMW0 #ASGCT #GenomicMedicine #GeneTherapy #CellTherapy
1
18 May 2022
Sangamo Research taking names…
17 May 2022
Today at #ASGCT22, we will showcase our zinc finger platform's capabilities for high-efficiency base editing in human cells. Learn how: bit.ly/3xKCMW0 #ASGCT #GenomicMedicine #GeneTherapy #CellTherapy
1
Jason Fontenot retweeted
17 May 2022
Today at #ASGCT22, we will showcase our zinc finger platform's capabilities for high-efficiency base editing in human cells. Learn how: bit.ly/3xKCMW0 #ASGCT #GenomicMedicine #GeneTherapy #CellTherapy
5
9
18 May 2022
Great work from our AAV engineering team.
18 May 2022
Today at #ASGCT22, we present our AAV capsid poster outlining the CNS delivery via intravenous administration, minimizing exposure to a patient’s pre-existing anti-AAV antibodies. View the abstract: bit.ly/3xKCMW0 #ASGCT #GenomicMedicine #GeneTherapy #CellTherapy
1
4
Jason Fontenot retweeted
28 Mar 2022
A new story from me — the California biotech Sangamo has dosed the first-ever patient with a new type of cell therapy, called a CAR-Treg.
Here's why that could be a big deal in biotech, bringing cell therapy to autoimmune diseases
businessinsider.com/exclusiv…
5
30
138
10 Nov 2021
We're on the cusp of transforming the treatment of autoimmune disease. Exciting times. @SangamoTx nature.com/articles/s41587-0…
5
6